TY - JOUR T1 - Efficacy and safety of abrocitinib monotherapy in adolescents and adults: a post hoc analysis of the phase 3 JAK1 atopic dermatitis efficacy and safety (JADE) REGIMEN clinical trial JO - Journal of Dermatological Treatment UR - http://dx.doi.org/10.1080/09546634.2023.2200866 PY - 2023/04/27 AU - Flohr C AU - Cork MJ AU - Ardern-Jones MR AU - Eichenfield LF AU - Barbarot S AU - Feeney C AU - Rojo R AU - Lazariciu I AU - Nesnas J ED - DO - DOI: 10.1080/09546634.2023.2200866 PB - Informa UK Limited VL - 34 IS - 1 Y2 - 2025/08/13 ER -